{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:59:39Z","timestamp":1792792779035,"version":"4.5.0"},"reference-count":12,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2014,1,12]],"date-time":"2014-01-12T00:00:00Z","timestamp":1389484800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transfusion"],"published-print":{"date-parts":[[2014,6]]},"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Transfusion reactions in pediatric populations have not been well studied. We investigated the incidence and type of transfusion reactions to platelets (<jats:styled-content style=\"fixed-case\">PLTs<\/jats:styled-content>) in a pediatric inpatient population.<\/jats:p><\/jats:sec><jats:sec><jats:title>Study Design and Methods<\/jats:title><jats:p>Over 1\u2009year, a retrospective review of all <jats:styled-content style=\"fixed-case\">PLT<\/jats:styled-content> transfusions given to pediatric inpatients (\u226418 years old) was performed at a single institution with application of the <jats:styled-content style=\"fixed-case\">US<\/jats:styled-content> hemovigilance reporting definitions. Intraoperative transfusions were excluded. Any signs or symptoms that could represent an acute transfusion reaction (<jats:styled-content style=\"fixed-case\">ATR<\/jats:styled-content>) within 24 hours after <jats:styled-content style=\"fixed-case\">PLT<\/jats:styled-content> transfusion were reviewed and classified based on the <jats:styled-content style=\"fixed-case\">US<\/jats:styled-content> hemovigilance reporting definitions.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Between <jats:styled-content style=\"fixed-case\">J<\/jats:styled-content>une 1, 2010, and <jats:styled-content style=\"fixed-case\">M<\/jats:styled-content>ay 31, 2011, a total of 805 <jats:styled-content style=\"fixed-case\">PLT<\/jats:styled-content> transfusions to 126 patients were identified as appropriate for inclusion. Of these 805 transfusions, 116 (14.4%) met the reporting criteria for <jats:styled-content style=\"fixed-case\">ATR<\/jats:styled-content>s. Some <jats:styled-content style=\"fixed-case\">PLT<\/jats:styled-content> transfusions were associated with multiple types of <jats:styled-content style=\"fixed-case\">ATR<\/jats:styled-content>s leading to 120 <jats:styled-content style=\"fixed-case\">ATR<\/jats:styled-content>s overall, as defined by the <jats:styled-content style=\"fixed-case\">US<\/jats:styled-content> hemovigilance reporting system. Of these 120 reportable <jats:styled-content style=\"fixed-case\">ATR<\/jats:styled-content>s, 54 (45.0%) transfusion\u2010associated dyspnea (<jats:styled-content style=\"fixed-case\">TAD<\/jats:styled-content>) reactions, 38 (31.7%) febrile nonhemolytic transfusion reactions, 15 (12.5%) allergic transfusion reactions, eight (6.7%) hypotensive transfusion reactions, and five (4.2%) transfusion\u2010associated cardiac overload reactions were identified. No resultant deaths associated with <jats:styled-content style=\"fixed-case\">ATR<\/jats:styled-content>s were observed. Of these reportable <jats:styled-content style=\"fixed-case\">ATR<\/jats:styled-content>s, only four (3.34%) were reported to the hospital transfusion service.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Our findings indicate that reportable <jats:styled-content style=\"fixed-case\">ATR<\/jats:styled-content>s in the pediatric populations may be more prevalent than previously reported and were underreported to our transfusion service. <jats:styled-content style=\"fixed-case\">TAD<\/jats:styled-content> encompassed the majority of reportable <jats:styled-content style=\"fixed-case\">ATR<\/jats:styled-content>s and is the main contributor to the increased rate of reportable <jats:styled-content style=\"fixed-case\">ATR<\/jats:styled-content>s.<\/jats:p><\/jats:sec>","DOI":"10.1111\/trf.12520","type":"journal-article","created":{"date-parts":[[2014,1,13]],"date-time":"2014-01-13T01:20:44Z","timestamp":1389576044000},"page":"1666-1672","source":"Crossref","is-referenced-by-count":30,"title":["Incidence of acute transfusion reactions to platelets in hospitalized pediatric patients based on the <scp>US<\/scp> hemovigilance reporting system"],"prefix":"10.1111","volume":"54","author":[{"given":"Ning","family":"Li","sequence":"first","affiliation":[{"name":"Department of Laboratory Medicine Yale University School of Medicine  New Haven Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence","family":"Williams","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine Yale University School of Medicine  New Haven Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiming","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine Yale University School of Medicine  New Haven Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YanYun","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine Yale University School of Medicine  New Haven Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2014,1,12]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.1993.331094054613.x"},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2004.03322.x"},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2010.10.012"},{"key":"e_1_2_7_5_1","unstructured":"AABB\/CDC Biovigilance Working Group.The National Healthcare Safety Network (NHSN) Manual: Biovigilance Component.2003. [cited 2013 Jun 26]. Available from:http:\/\/www.cdc.gov\/nhsn\/PDFs\/Biovigilance\/BV\u2010HV\u2010protocol\u2010current.pdf"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2006.00995.x"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.2002.00070.x"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2008.07022.x"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tmrv.2006.05.002"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.1159\/000151349"},{"key":"e_1_2_7_11_1","unstructured":"TTISS Working Group.2004\u20102005 Program report for the National Transfusion Transmitted Injuries Surveillance System (TTISS) Public Health Agency of Canada.2008. [cited 2013 Jul 12]. Available from:http:\/\/www.phac\u2010aspc.gc.ca\/hcai\u2010iamss\/tti\u2010it\/"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.CCM.0000214311.56231.23"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2011.03247.x"}],"container-title":["Transfusion"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Ftrf.12520","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/trf.12520","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,30]],"date-time":"2023-09-30T00:19:31Z","timestamp":1696033171000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/trf.12520"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1,12]]},"references-count":12,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["10.1111\/trf.12520"],"URL":"https:\/\/doi.org\/10.1111\/trf.12520","archive":["Portico"],"relation":{},"ISSN":["0041-1132","1537-2995"],"issn-type":[{"value":"0041-1132","type":"print"},{"value":"1537-2995","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,1,12]]}}}